Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Cohort on Imprinting Disorders and Their Metabolic Consequences

NCT05945576 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT05945576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Cohort on Imprinting Disorders and Their Metabolic Consequences
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Observational
Overall status
Recruiting
Start date
March 10, 2017
Completion date
March 31, 2028
Enrollment
2,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

angelman syndrome, beckwith-wiedemann syndrome, familial precocious puberty, kagami-ogata syndrome, prader-willi syndrome, pseudohypoparathyroidism, silver russell syndrome, temple syndrome, transient neonatal diabetes mellitus